Enovix (NASDAQ:ENVX) Trading 11.7% Higher – Should You Buy?

Enovix Corporation (NASDAQ:ENVX)’s stock price traded up 11.7% during mid-day trading on Monday . The stock traded as high as $7.25 and last traded at $7.3860. 4,825,365 shares were traded during trading, a decline of 20% from the average session volume of 6,052,943 shares. The stock had previously closed at $6.61.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Bank of America started coverage on Enovix in a research report on Thursday, March 12th. They set a “neutral” rating and a $6.00 price objective for the company. Wells Fargo & Company set a $6.00 target price on Enovix in a report on Thursday, March 12th. B. Riley Financial reduced their target price on Enovix from $17.00 to $10.00 and set a “buy” rating for the company in a report on Monday, March 2nd. Craig Hallum reduced their target price on Enovix from $16.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Finally, TD Cowen reduced their target price on Enovix from $15.00 to $7.50 and set a “hold” rating for the company in a report on Thursday, February 26th. Six analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $14.05.

Enovix Stock Up 4.6%

The company has a 50 day simple moving average of $5.74 and a 200 day simple moving average of $7.18. The company has a debt-to-equity ratio of 1.90, a quick ratio of 8.13 and a current ratio of 8.34.

Enovix (NASDAQ:ENVX) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.01. The firm had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. Enovix had a negative return on equity of 64.29% and a negative net margin of 492.57%.The firm’s revenue was up 49.1% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.15) EPS. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, equities research analysts expect that Enovix Corporation will post -0.81 earnings per share for the current fiscal year.

Institutional Trading of Enovix

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Jupiter Asset Management Ltd. purchased a new position in shares of Enovix during the 3rd quarter worth approximately $2,465,000. Granahan Investment Management LLC raised its stake in shares of Enovix by 17.5% during the 3rd quarter. Granahan Investment Management LLC now owns 1,749,649 shares of the company’s stock worth $17,444,000 after buying an additional 260,085 shares in the last quarter. DNB Asset Management AS raised its stake in shares of Enovix by 378.6% during the 3rd quarter. DNB Asset Management AS now owns 210,748 shares of the company’s stock worth $2,101,000 after buying an additional 166,712 shares in the last quarter. Blair William & Co. IL raised its stake in shares of Enovix by 49.4% during the 3rd quarter. Blair William & Co. IL now owns 476,450 shares of the company’s stock worth $4,750,000 after buying an additional 157,452 shares in the last quarter. Finally, Fred Alger Management LLC raised its stake in shares of Enovix by 9.4% during the 3rd quarter. Fred Alger Management LLC now owns 1,442,986 shares of the company’s stock worth $14,387,000 after buying an additional 123,814 shares in the last quarter. 50.92% of the stock is owned by hedge funds and other institutional investors.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.